We further demonstrate that the activation of insulin-like growth factor-1 receptor (IGF1R) signaling pathway in epithelial cancer cells promotes ITGAV expression and induces EMP in response to tumor microenvironment (TME)-derived factors. This evidence concerns the gene IGF1R and neoplasm.